person

Antony K.

Country
France
Department
Nuclear Medicine

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
16
Sites with multiple studies

Has run more than one trial at 16 of 61 partner sites.

Specializations

Neuroendocrine Oncology

This clinical investigator specializes in the treatment of neuroendocrine tumors (NETs), with particular emphasis on gastroenteropancreatic neuroendocrine tumors (GEP-NETs). Their research interests focus on advanced therapeutic approaches for patients with inoperable and progressive disease.

  • Intestinal NETs
  • Pancreatic NETs
  • Gastroenteropancreatic NETs

The investigator explores innovative treatment strategies for well-differentiated neuroendocrine tumors.

Nuclear Medicine Applications

Their expertise extends to Peptide Receptor Radionuclide Therapy (PRRT), specifically utilizing advanced radiopharmaceuticals in the treatment of neuroendocrine tumors. The investigator studies various treatment schemas and their effectiveness in disease management.

  • Radionuclide therapy
  • Treatment optimization
  • Therapeutic sequencing

Areas of focus include the evaluation of retreatment protocols and comparative effectiveness of different therapeutic approaches.

Progressive Disease Management

The investigator concentrates on developing treatment strategies for progressive neuroendocrine tumors, particularly in cases where surgical intervention is not possible. Their work encompasses both initial treatment approaches and management of disease progression.

  • Disease progression monitoring
  • Treatment response assessment
  • Surveillance protocols

The research includes evaluation of survival outcomes and disease control in advanced cases.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.